Kanghua Biological
One of the 13 enterprises with full vaccine production capacity in Chengdu Economic and Technological Development Zone, covering an area of 30000 square meters.
Launch date
Market cap
CAD1.1b
Enterprise valuation
CAD1.0b (Public information from Sep 2024)
Share price
CNY45.01 300841.SZ
Chengdu Sichuan (HQ)
Financials
Estimates*
CNY | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
---|---|---|---|---|---|---|---|
Revenues | 1.0b | 1.3b | 1.4b | 1.6b | 1.9b | 2.2b | 2.4b |
% growth | 87 % | 24 % | 12 % | 9 % | 20 % | 14 % | 12 % |
EBITDA | 502m | 953m | 767m | 677m | 890m | 997m | 1.1b |
% EBITDA margin | 48 % | 74 % | 53 % | 43 % | 47 % | 46 % | 46 % |
Profit | 408m | 829m | 598m | 509m | 704m | 791m | 885m |
% profit margin | 39 % | 64 % | 41 % | 32 % | 37 % | 37 % | 37 % |
EV / revenue | 27.1x | 14.8x | 7.8x | 6.6x | 3.6x | 3.2x | 2.8x |
EV / EBITDA | 56.0x | 20.1x | 14.8x | 15.3x | 7.7x | 6.8x | 6.2x |
R&D budget | 58.3m | 78.9m | 180m | 253m | - | - | - |
R&D % of revenue | 6 % | 6 % | 12 % | 16 % | - | - | - |
Date | Investors | Amount | Round |
---|---|---|---|
* | N/A | Growth Equity VC | |
N/A | $149m | IPO | |
Total Funding | - |
Recent News about Kanghua Biological
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.